↓ Skip to main content

Risk Evaluation of Proton Pump Inhibitors for Panitumumab-Related Hypomagnesemia in Patients with Metastatic Colorectal Cancer

Overview of attention for article published in Biological and Pharmaceutical Bulletin, January 2024
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
4 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Risk Evaluation of Proton Pump Inhibitors for Panitumumab-Related Hypomagnesemia in Patients with Metastatic Colorectal Cancer
Published in
Biological and Pharmaceutical Bulletin, January 2024
DOI 10.1248/bpb.b23-00641
Pubmed ID
Authors

Hideyuki Katsura, Yukio Suga, Anna Kubo, Hayato Sugimura, Kaname Kumatani, Kazunobu Haruki, Miwa Yonezawa, Ayaka Narita, Rei Ishijima, Hiroaki Ikesue, Hitomi Toi, Naoko Takata

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 25%
Lecturer 1 25%
Student > Postgraduate 1 25%
Unknown 1 25%
Readers by discipline Count As %
Medicine and Dentistry 2 50%
Nursing and Health Professions 1 25%
Unknown 1 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 March 2024.
All research outputs
#15,751,292
of 25,393,528 outputs
Outputs from Biological and Pharmaceutical Bulletin
#2,252
of 3,268 outputs
Outputs of similar age
#144,543
of 334,222 outputs
Outputs of similar age from Biological and Pharmaceutical Bulletin
#5
of 19 outputs
Altmetric has tracked 25,393,528 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,268 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 334,222 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.